Fundz

Accu Vein Inc. reported raising $1.4 Million in an initial SEC Form D filing, from an offering of $1.4 Million

PRIVATENov 13, 2017

Amount Raised

$1.4 Million

$1.4 Million sold, per SEC Form D (first sale Nov 13, 2017)

Round Type

Seed

New YorkHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as AccuVein Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Atterocor, Inc. raised $50M on December 28, 2017.
  • Imago Systems, Inc. raised $785K (Seed) on December 28, 2017.
  • Avantor, Inc. raised an undisclosed amount on December 28, 2017.
  • EGOSCUE INC raised $721 (Pre-Seed) on December 28, 2017.
  • Admittance Technologies, Inc. raised $97K (Seed) on December 27, 2017.
  • Beta Bionics raised $2.5M (Seed) on December 27, 2017.

Who to call at AccuVein Inc., and when

A new round usually means AccuVein Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AccuVein Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AccuVein Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AccuVein Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AccuVein Inc.

Location

3243 ROUTE 112, BUILDING 1, SUITE 2

New York, United States

About

AccuVein Inc. is the global leader in vein illumination. The AV400 vein illumination system allows health care professionals to see a map of peripheral veins on the skin’s surface with the goal of improving vascular access procedures including blood draw, IV infusion and blood donation as well as for avoiding veins for cosmetic injectable procedures. To see a demonstration of AccuVein in action, please visit www.accuvein.com or call 877-772-5607. 
AccuVein is the world’s only portable, non-contact vein illumination solution. AccuVein is in use at more than 3,000 hospitals and available for sale in over 100 countries worldwide. An Essential Tool The AccuVein AV400 displays a map of the vasculature on the surface of the skin.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AccuVein Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for AccuVein Inc.'s next move

See what Strategic adds

AccuVein Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.